Welcome to our dedicated page for Integer Hldgs news (Ticker: ITGR), a resource for investors and traders seeking the latest updates and insights on Integer Hldgs stock.
Integer Holdings Corporation (NYSE: ITGR) is a premier global player in the medical device outsourcing (MDO) industry. With a reputation for excellence in innovation and manufacturing, Integer delivers comprehensive end-to-end solutions that both enhance patient lives and meet the needs of their customers. The company's core business revolves around the creation of medical device components, which are developed and manufactured for original equipment manufacturers (OEMs) across various medical sectors including cardiac, neuromodulation, vascular, portable medical, and orthopedics markets.
In addition to their medical device segment, Integer also operates through Electrochem, an entity focused on developing custom batteries for niche applications in energy, military, and environmental markets. Their portfolio includes renowned brands such as Greatbatch™ Medical and Lake Region Medical™. The company has a substantial footprint in the United States, earning over half of its revenue domestically.
Integer has recently marked significant milestones, including its acquisition of InNeuroCo, Inc., which has bolstered its neurovascular catheter capabilities. The third quarter of 2023 saw Integer reporting organic sales growth of 18% and a 39% increase in adjusted operating income. The company has ongoing strategic expansions, particularly in Europe, with new facilities in Ireland designed to enhance their high-volume manufacturing capacity and R&D capabilities.
Financially, Integer continues to show robust growth with an increase in full-year sales outlook. Their recent acquisition of Pulse Technologies underscores their strategy to enhance precision micro-machining capabilities for medical device components, further expanding their market reach and development capacity. Integer also anticipates strong financial performance in 2024, with projected sales growth between 9% and 11%, and adjusted operating income growth ranging from 13% to 20%.
The company actively engages with investors, providing real-time updates through their comprehensive Investor Relations section on their website. They have streamlined their operations and expanded their capabilities to ensure a seamless transition from R&D to operations for their global clientele.
Learn more about Integer at www.integer.net.
Integer Holdings (NYSE: ITGR), a leading global medical device contract development and manufacturing organization, announced its participation in the 2024 Truist Securities MedTech Conference.
The event will take place in Boston on June 17-18, 2024. Integer's President and CEO, Joseph Dziedzic, will present during a fireside chat scheduled for June 18 at 1:55 p.m. ET.
A live webcast of the presentation will be available on the Investor Relations section of the company’s website.
Integer Holdings will showcase its strategic investments at Heart Rhythm 2024, focusing on comprehensive end-to-end solutions to support customers' growth and innovation. The company's recent acquisition of Pulse Technologies brings advanced surface texturing and coating technologies, enhancing the performance and reliability of medical devices across various applications.
Integer Holdings (NYSE: ITGR) will present at the 2024 Bank of America Securities Healthcare Conference on May 14. CEO Joseph Dziedzic will speak at 10:40 a.m. PDT. The live webcast can be accessed on the Investor Relations section of the Integer website.